|
|
| IPO Open | Dec 20, 2017 |
| IPO Close | Dec 22, 2017 |
| IPO Price | ₹30 |
| Face Value | ₹10 |
| IPO Size | ₹6.59 Cr |
| Listing At | NSE SME |
| Lot Size | 4000 |
Dec 15, 2017 4:24:00 PM
The IPO will allow Samara Capital an opportunity to dilute its 51% stake in the holding company of More Retail, Witzig Advisory Services. Samara Capital owns the stake through Samara Alternate ...
Publish by : IndiatimesSep 28, 2022 3:30:00 AM
Ajooni Biotech Ltd., incorporated in the year 2010, is a company (having a market cap of Rs 40.22 Crore) operating in Agriculture/Horticulture/Livestock sector ...
Publish by : IndiatimesSep 9, 2022 10:30:00 AM
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking for 'win' or to ...
Publish by : InvestingAug 2, 2021 6:43:00 PM
Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo ...
Publish by : Yahoo FinanceSep 26, 2022 4:55:00 PM
IPOs have been on pause in 2022 due to high inflation, rising interest rates, and a turbulent market. However, the biotech industry is still attracting investors and venture capitalists.
Publish by : Yahoo FinanceSep 9, 2022 3:30:00 AM
and that biotech IPOs have done exceptionally well of late. “The phone is ringing now,” Blair says, with LPs checking references on venture capitalists. He predicts that some of the VC firms ...
Publish by : XconomySep 13, 2022 12:32:00 PM
This week, the Cambridge, Massachusetts-based biotech aims to sell 9 million shares at an expected price of between $16 to $18 each. At the high end of that range, Third Harmonic could raise as much ...
Publish by : BioPharma DiveSep 15, 2022 5:20:00 PM
The Cambridge, Massachusetts-based biotech said Wednesday evening that it sold 10.9 million shares for $17 apiece. Total proceeds could be higher if the banks underwriting the offering buy more shares ...
Publish by : BioPharma DiveMay 19, 2020 7:34:00 PM
Legend Biotech is spinning out from parent firm GenScript Biotech to pursue treatments in CAR T cell therapies for multiple myeloma. Legend Biotech is spinning out from parent firm GenScript ...
Publish by : TheStreet.comAug 18, 2020 1:40:00 AM
For the most part, investors have had reason to be pleased. Shares in the latest batch of biotech IPOs are mostly trading higher than their offering prices. , a German genetic toolkit company ...
Publish by : TheStreet.comSep 15, 2022 3:30:00 AM
We also discuss the White House’s investment in biotech, a bellwether IPO, and the latest twist in the Merck-Seagen saga. Biotech Startups and Venture Capital Reporter Allison is a biotech ...
Publish by : STATSep 29, 2022 3:30:00 AM
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex ...
Publish by : InvestingThe issue of Ajooni Biotech Limited opens on Dec 20, 2017 and closes for subscription on Dec 22, 2017. The equity shares of the company to be list at NSE SME. The price band for the issue has been fixed at Rs 30.
Ajooni Biotech Limited is entering in the capital market with an IPO of 21,96,000 Equity Shares of Rs 10 aggregating up to Rs. 6.59 Crore. The price band for the issue has been fixed at Rs 30 Per Equity Share.
Incorporated in 2010, Ajooni Biotech Limited is Mohali, Punjab based company engaged in manufacturing, producing, processing and supplying of Cattle feed, Nutrients related to cattle feed and manufacturing & production of Animal health care supplements.
The issue opens on Dec 20, 2017 and closes for subscription on Dec 22, 2017. The equity shares of the company to be list at NSE SME platform.
The Ajooni Biotech IPO is proposed to open on Dec 20, 2017. The IPO application ends on Dec 22, 2017.
Retail investors can apply in the retail or non-institutional investor category from Dec 20, 2017 to Dec 22, 2017. The Ajooni Biotech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Ajooni Biotech IPO will open for subscription on Dec 20, 2017. The public issue will close on Dec 22, 2017.
Useful Articles
30 days brokerage free trading
Free - Relationship Manager
Free - Classroom Training
|
|
